Holmusk

About Holmusk

Holmusk is a pioneering startup in the healthcare technology sector, focusing on behavioral health. The company operates in the U.S. market, serving a diverse clientele that includes researchers, clinicians, and payers. Holmusk's primary offering is the NeuroBlu Database, a comprehensive clinical database that captures and maps de-identified data from patient electronic health records across the U.S. This database serves as a single source of truth, reflecting how behavioral health care is delivered in real-world settings.

Holmusk's business model revolves around the use of real-world data and analytics to revolutionize the behavioral health landscape. The company's evidence engine, NeuroBlu, enables researchers to build patient cohorts, conduct studies with an unprecedented level of detail, and generate impactful evidence. This is achieved through the application of natural language processing models, which extract valuable information from unstructured clinical notes within the electronic health record and transform it into standardized measures.

In simpler terms, Holmusk uses advanced technology to turn raw health data into useful information that can guide decisions for successful treatment development, efficient care delivery, and improved patient outcomes. The company also offers a range of digital solutions aimed at harnessing real-world data to improve behavioral health.

Holmusk generates revenue by providing access to its database and digital solutions. Clients can access insights in just a few clicks, making it a convenient and valuable tool for anyone involved in behavioral health care.